Skip to content
Credit reportVerdict and grounds
Made on 22-11-2026 at 12:11
Reference CK-0784459685-20261122

BIO INX

ActivePrivate limited company0784.459.685Technologiepark-Zwijnaarde 66, 9052 Ghent
Research and development on biotechnology (NACE 72101) · founded in 2022 · 5 employees on 31-12-2025

Sources: the KBO register on 22-11-2026; the National Bank, 2025 annual accounts filed on 30-06-2026; the Belgian Official Gazette, latest deed of 24-10-2024.

Credit verdict
Checked score 2025
The score, from 0 to 100, reflects the bankruptcy probability and the standing among sector peers.
Bankruptcy probability within 12 months
The median of 932 micro companies in the research and development sector (NACE 72) is 0.1%.
Gross margin
-€14,253
-€66,700 in 2024
Net result
-€322,253
-€294,805 in 2024
Equity
-€272,921
€49,332 in 2024
Cash
€173,530
▼ 54.5% against 2024

Grounds

the facts the verdict rests on, each with its source
  1. In 2025, BIO INX made a loss of €322,253. Equity went from €49,332 to -€272,921.Annual accounts 2025 page 2
  2. The last three annual accounts came in on time. The 2025 accounts were filed 31 days before the end of the term.National Bank, filing of 30-06-2026 page 4

Representation

The signing rule is in the deed of 24-10-2024.

Articles of association, Belgian Official Gazette of 24-10-2024, deed 24439141

Ownership

holds 29.05% of the shares. Its equity stood at €2.8m on 31-12-2025.

Annual accounts 2025 of

BIO INX · 0784.459.685 · credit report of 22-11-2026Page 1 of 5
BIO INX0784.459.685 · report of 22-11-2026

Financial situation

Annual accounts 2023 to 2025, as filed with the National Bank

Gross margin and net resultin €m

2023-0.12024-0.072025-0.012023-0.32024-0.32025-0.3
gross marginnet result

Equity and debtsin €m

202320242025-0.31.5
equitydebts

Cashin €m

20230.0620240.420250.2
on the balance sheet date
Financial year202320 months20242025Trend
Results
Gross margin-€120,925-€66,700-€14,253
Operating result-€329,814-€279,697-€298,587
Net result-€331,463-€294,805-€322,253
Balance sheet at the closing date
Equity€194,137€49,332-€272,921
Debts€208,257€1.7m€1.5m
Debts due after more than one year-€196,626€510,173
Debts due within one year€86,757€251,295€249,846
Cash€61,202€381,754€173,530
Balance sheet total€402,394€1.7m€1.2m
Operations
Employees in full-time equivalents1.82.84.0
Ratios
Solvency48.2%2.8%-22.1%
Liquidity3.035.523.79

Source: Annual accounts 2025, abbreviated format, filed on 30-06-2026 (2026-00218920); Annual accounts 2024, abbreviated format, filed on 10-07-2025 (2025-00265574); Annual accounts 2023, filed on 09-07-2024 (2024-00226895).

Debts fell by €179,895 in 2025.

The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.

The financial year to 31-12-2023 ran for 20 months.

BIO INX · 0784.459.685 · credit report of 22-11-2026Page 2 of 5
BIO INX0784.459.685 · report of 22-11-2026

Board, signature and ownership

Position on 22-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts

Who represents the company

The signing rule is in the deed of 24-10-2024.

Articles of association, Belgian Official Gazette of 24-10-2024, deed 24439141

Board

three directors in office
Director (not named in the articles)current term since 12-09-2022
term without a fixed enddeed of 06-04-2022
Directorsince 12-09-2022
Director (not named in the articles)current term since 12-09-2022
term without a fixed enddeed of 06-04-2022

also sits on the board of 1 other company.

Ownership and group

Shareholders

holds 29.05% of the shares. Its equity stood at €2.8m on 31-12-2025.

Annual accounts 2025 of

Board changes

resigns as director. Discharge granted to . General meeting of 30-08-2024.

Gazette, deed 24140175

acts as permanent representative. General meeting of 16-11-2023.

Gazette, deed 24059673

appointed as director. acts as permanent representative. General meeting of 06-09-2023.

Gazette, deed 23133581
BIO INX · 0784.459.685 · credit report of 22-11-2026Page 3 of 5
BIO INX0784.459.685 · report of 22-11-2026

Events and comparison

Every event since the founding, newest first

Annual accounts 2025 filed, 31 days before the deadline.

NBB filing

Annual accounts 2024 filed, 21 days before the deadline.

NBB filing

Capital increase of €150,000, 1,920 new shares. holds 1,920 shares.

Gazette, deed 24439141

Annual accounts 2023 filed, 22 days before the deadline.

NBB filing

Incorporation. Founding capital of €25,600, 25,600 shares. Founded by , , and 2 others. (director) and (director) appointed. Published on 06-04-2022.

Gazette, deed 22323035

First establishment. Technologiepark-Zwijnaarde 66, Ghent.

Comparable companies, two years later

In July 2024, 7,648 companies had the same profile as BIO INX has now: micro, 2 to 5 years old, negative equity and a loss of 10% of the balance sheet or more. Two years later 84.7% were still trading, 6.1% had stopped another way and 9.2% had gone bankrupt.

still trading 84.7% stopped another way 6.1% bankrupt 9.2%

The return on assets of BIO INX, -26.1%, is higher than at 21% of the 340 companies filing abbreviated accounts in research and development (NACE 72) in 2025.

Other findings

Peppol

Reachable for e-invoices, under 0208:0784459685.

Sanctions lists

Staff

5 employees on 31-12-2025, 4.0 full-time equivalents on average over the year.

BIO INX · 0784.459.685 · credit report of 22-11-2026Page 4 of 5
BIO INX0784.459.685 · report of 22-11-2026

Sources and method

Where each fact in this report comes from

SourceWhatDateReference
KBO registerRegistration, legal situation, activity, establishment units22-11-2026KBO 0784.459.685
National Bank of BelgiumAnnual accounts 2025, abbreviated format30-06-20262026-00218920
National Bank of BelgiumAnnual accounts 2024, abbreviated format10-07-20252025-00265574
National Bank of BelgiumAnnual accounts 2023 to 202309-07-20242024-00226895
Belgian Official GazetteArticles of association with the signing rule24-10-2024deed 24439141
Belgian Official GazetteBoard27-09-2024deed 24140175
Belgian Official GazetteBoard12-04-2024deed 24059673
Belgian Official GazetteBoard19-10-2023deed 23133581
Peppol DirectoryRegistration for e-invoices0208:0784459685
Sanctions lists EU, UN, US (OFAC) and UKComparison of the name19-11-2026
CheckedChecked score, bankruptcy probability, credit, comparable companies21-11-2026bankruptcy model of 21 November 2026

Method

Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.

Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 21 November 2026, computed on 21-11-2026.

Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.

Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.

The scores and ratios are Checked's own calculations, not a credit decision.

BIO INX · 0784.459.685 · credit report of 22-11-2026Page 5 of 5